The Scottish Medicines Consortium (SMC) which advises on newly licensed medicines for use by NHSScotland has today (Monday 8 November) published advice acceptin... Read More...
• High blood cholesterol increases the risk of cardiovascular disease (CVD), which was the leading
cause of death in Scotland in 2020, equating to nearly 50 pe... Read More...
The Scottish Medicines Consortium (SMC) has today announced that Ofev® (nintedanib) has been accepted for use by NHSScotland for the treatment of adult patients... Read More...
Positive indication means upadacitinib will be available to those with previously treated severe active RA*
SMC approval is based on data from pivotal Ph... Read More...
Scottish Medicines Consortium (SMC) has accepted PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer.
Leupro... Read More...
The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today published advice on four new medicines.
... Read More...
Healthcare Professional ONLY
This website is intended for Healthcare professionals only
Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors
